Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.

S L, Whittle,; R A, Hughes,

doi:10.1093/rheumatology/keh088

Public

Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.

Published in Rheumatology (Oxford, England) • Mar 1, 2004

Authors:

Whittle, S L

Hughes, R A

Abstract

OBJECTIVES: The folate antagonist methotrexate (MTX) has become established as the most commonly used disease-modifying anti-rheumatic drug (DMARD) in the treatment of rheumatoid arthritis (RA) but is commonly discontinued due to adverse effects. Adverse effects are thought to be mediated via folate...

Subject

Antirheumatic Agents

Arthritis

Rheumatoid

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!